SanBio Company Limited

TSE:4592 Stock Report

Market Cap: JP¥52.4b

SanBio Past Earnings Performance

Past criteria checks 0/6

SanBio has been growing earnings at an average annual rate of 8.9%, while the Biotechs industry saw earnings growing at 11.6% annually. Revenues have been declining at an average rate of 100.1% per year.

Key information

8.9%

Earnings growth rate

14.6%

EPS growth rate

Biotechs Industry Growth31.9%
Revenue growth rate-100.1%
Return on equity-472.5%
Net Marginn/a
Last Earnings Update31 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How SanBio makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:4592 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 240-2,9141,2282,069
31 Jul 240-2,1661,2651,761
30 Apr 240-2,1621,5562,188
31 Jan 240-2,6441,6902,849
31 Oct 230-5,6841,6363,584
31 Jul 230-5,1921,7524,610
30 Apr 230-5,8701,7205,796
31 Jan 230-5,5591,7816,118
31 Oct 220-3,3201,8956,390
31 Jul 220-4,6971,8656,324
30 Apr 220-4,1321,7255,199
31 Jan 220-4,6771,6654,955
31 Oct 210-1,6591,7094,643
31 Jul 210-2,3121,7594,524
30 Apr 210-2,7381,7594,340
31 Jan 210-3,3851,7304,071
31 Oct 2023-6,7181,6294,439
31 Jul 2020-6,3161,5794,112
30 Apr 20258-5,9281,6484,089
31 Jan 20447-5,1571,6064,327
31 Oct 19597-4,6511,3134,086
31 Jul 19753-3,9271,1104,065
30 Apr 19772-2,8198263,844
31 Jan 19741-2,9206733,721
31 Oct 18687-2,3317223,654
31 Jul 18656-2,7056763,824
30 Apr 18525-3,6806864,199
31 Jan 18490-3,9407124,156
31 Oct 17562-3,3027913,641
31 Jul 17514-2,9668543,115
30 Apr 17447-2,6558402,621
31 Jan 17949-1,8358062,058
31 Oct 16833-2,2097221,884
31 Jul 161,447-1,6936731,954
30 Apr 161,515-1,1566251,856
31 Jan 161,174-9886041,695
31 Oct 151,208-6475481,390
31 Jan 153,2291,736357623
31 Jan 14204-589258530

Quality Earnings: 4592 is currently unprofitable.

Growing Profit Margin: 4592 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4592 is unprofitable, but has reduced losses over the past 5 years at a rate of 8.9% per year.

Accelerating Growth: Unable to compare 4592's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4592 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-36.8%).

Return on Equity

High ROE: 4592 has a negative Return on Equity (-472.47%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 20:24
End of Day Share Price 2024/12/27 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SanBio Company Limited is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hidemaru YamaguchiCitigroup Inc
Miyabi YamakitaJefferies LLC
Stephen BarkerJefferies LLC